ORAMED LTD has a total of 65 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals are PHARMACY AND THERAPEUTIC ADVIS, HUBRECHT LAB and ZARODEX THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Japan | 7 | |
#4 | Canada | 6 | |
#5 | China | 6 | |
#6 | Hong Kong | 5 | |
#7 | Australia | 4 | |
#8 | WIPO (World Intellectual Property Organization) | 4 | |
#9 | Brazil | 3 | |
#10 | New Zealand | 2 | |
#11 | Russian Federation | 2 | |
#12 | South Africa | 2 | |
#13 | Israel | 1 | |
#14 | Republic of Korea | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kidron Miriam | 50 |
#2 | Miriam Kidron | 11 |
#3 | Arbit Ehud | 8 |
#4 | Nagaraju Ramachandra | 6 |
#5 | Kundu Prabuddha | 6 |
#6 | Arora Nupur Mehrotra | 6 |
#7 | Hershko Avraham | 6 |
#8 | Arora Kajal | 6 |
#9 | Avraham Hershko | 2 |
#10 | Ehud Arbit | 2 |
Publication | Filing date | Title |
---|---|---|
SG11202012340SA | Recombinant protease inhibitor-containing compositions, methods for producing same and uses thereof | |
EP2941267A2 | Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof | |
AU2013237663A1 | Methods and compositions for oral administration of proteins | |
CN104244969A | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | |
CN104159598A | Methods and compositions for treating diabetes | |
AU2009245294A1 | Methods and compositions for oral administration of exenatide |